Li, M.* et al. Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas. Endocr. Relat. Cancer 30:12 (2023)
Haberbosch, L.* et al. Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients. Endocr. Relat. Cancer 29, 121-128 (2022)
Wang, K.* et al. Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures. Endocr. Relat. Cancer 29, 285-306 (2022)
Stauffer, E. et al. Transcriptomic landscape of radiation-induced murine thyroid proliferative lesions. Endocr. Relat. Cancer 28, 213-224 (2021)
Lutz, S.Z. et al. Higher prevalence of lymph node metastasis in prostate cancer in patients with diabetes. Endocr. Relat. Cancer 25, L19-L22 (2018)
Molatore, S. et al. Characterization of neuroendocrine tumors in heterozygous mutant MENX rats: A novel model of invasive medullary thyroid carcinoma. Endocr. Relat. Cancer 25, 145-162 (2018)
Lee, M.S. et al. Targeting PI3K/mTOR signaling exerts potent antitumor activity in pheochromocytoma in vivo. Endocr. Relat. Cancer 24, 1-15 (2017)
Mohr, H. & Pellegata, N.S. Animal models of MEN1. Endocr. Relat. Cancer 24, T161-T177 (2017)
Beckers, A.* et al. X-Linked Acrogigantism (X-LAG) syndrome: Clinical profile and therapeutic responses. Endocr. Relat. Cancer 22, 353-367 (2015)
Lee, M.S. et al. SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary. Endocr. Relat. Cancer 22, 111-119 (2015)
Sekiya, T.* et al. p27 variant and corticotropinoma susceptibility: A genetic and in vitro study. Endocr. Relat. Cancer 21, 395-404 (2014)
Heiliger, K.-J. et al. Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice. Endocr. Relat. Cancer 19, 409-421 (2012)
Tichomirowa, M.A.* et al. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds. Endocr. Relat. Cancer 19, 233-241 (2012)
Unger, K. et al. Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations. Endocr. Relat. Cancer 17, 87-98 (2010)